Česká urologie.
2009 ;
13 (1) :
104-105.
- MeSH
- Benzenesulfonates administration & dosage adverse effects therapeutic use MeSH
- Diphosphonates administration & dosage adverse effects therapeutic use MeSH
- Estramustine administration & dosage adverse effects therapeutic use MeSH
- Humans MeSH
- Evidence-Based Medicine trends MeSH
- Mitoxantrone administration & dosage adverse effects therapeutic use MeSH
- Antibodies, Monoclonal therapeutic use MeSH
- Prostatic Neoplasms complications therapy MeSH
- Neoplasms, Hormone-Dependent complications MeSH
- Prednisone administration & dosage adverse effects therapeutic use MeSH
- Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
- Radiotherapy utilization MeSH
- Taxoids administration & dosage adverse effects therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Congress MeSH
Urologické listy.
2007 ;
5 (4) :
39-47.
- MeSH
- Chemotherapy, Adjuvant methods utilization MeSH
- Survival Analysis MeSH
- Androgens pharmacology therapeutic use MeSH
- Antimetabolites administration & dosage pharmacology therapeutic use MeSH
- Diphosphonates administration & dosage pharmacology therapeutic use MeSH
- Cyclophosphamide administration & dosage pharmacology therapeutic use MeSH
- Doxorubicin administration & dosage pharmacology therapeutic use MeSH
- Estramustine administration & dosage pharmacology therapeutic use MeSH
- Clinical Trials, Phase III as Topic MeSH
- Drug Therapy, Combination MeSH
- Humans MeSH
- Neoplasm Metastasis drug therapy therapy MeSH
- Prostatic Neoplasms drug therapy therapy MeSH
- Platinum Compounds administration & dosage pharmacology therapeutic use MeSH
- Taxoids pharmacology therapeutic use MeSH
- Vinca Alkaloids administration & dosage pharmacology therapeutic use MeSH
- Check Tag
- Humans MeSH
- Male MeSH
Edukační sborník.
2006 ;
() :
202-204.
- Keywords
- hormonálně independentní karcinom prostaty,
- MeSH
- Estramustine administration & dosage adverse effects therapeutic use MeSH
- Drug Therapy MeSH
- Antineoplastic Agents, Hormonal administration & dosage adverse effects therapeutic use MeSH
- Quality of Life MeSH
- Medical Oncology MeSH
- Humans MeSH
- Meta-Analysis as Topic MeSH
- Mitoxantrone administration & dosage adverse effects therapeutic use MeSH
- Prostatic Neoplasms diagnosis etiology therapy MeSH
- Prednisone administration & dosage adverse effects therapeutic use MeSH
- Prostate-Specific Antigen isolation & purification MeSH
- Antineoplastic Combined Chemotherapy Protocols * MeSH
- Statistics as Topic MeSH
- Taxoids administration & dosage adverse effects therapeutic use MeSH
- Outcome and Process Assessment, Health Care * MeSH
- Check Tag
- Humans MeSH
Urologické listy.
2004 ;
Roč. 2 (č. 4) :
s. 26-29.
- MeSH
- Chemotherapy, Adjuvant utilization MeSH
- Estramustine administration & dosage adverse effects therapeutic use MeSH
- Carcinoma therapy MeSH
- Combined Modality Therapy methods utilization MeSH
- Mitoxantrone administration & dosage adverse effects therapeutic use MeSH
- Prostatic Neoplasms therapy MeSH
- Paclitaxel administration & dosage adverse effects therapeutic use MeSH
- Publication type
- Review MeSH
